This is BrainsWay’s global website. The website includes information on clinical indications that were not cleared by the FDA and are considered investigational by the U.S. medical device regulations. BrainsWay D treatment is FDA cleared for patients with MDD who failed to respond to one or more anti-depressants in the current episode.
Ms. Sarid is a business oriented senior executive with over 30 years of operation, sales, financial and strategic experience in international hi-tech companies.
Received at the end of 1998 the award of the CFO of the year in Israel of the CFO organization and the head of economic activities in Israel.
01/14 – present – chairman of Hairstetics
01/17 – present – board member of Cherry Imaging.
03/14 – 7/17 – Syneron Medical Ltd.
VP Beauty and Dental , Chairman of China activities. Focus on the strategic actives of Syneron in China , expanding its activities in China. Manage the company’s dental business, including sales, marketing and operations. Sold the dental Business to a Chinese organization. Responsible for building the company’s beauty business including initiating strategic alternatives.
01/14- Present Chairman of Hairstetics- a private company in the field of hair implant , funded by Potifax and Generally.
01/12 – 08/13 – Alma Lasers Ltd.
President. Responsible for the strategic alternatives of the company. Initiate the sale of the company and managed the entire process including identifying strategic and financial acquirers, the due diligence process and negotiations.
01/13 – 8/16 Director at MCS , member of the audit and compensation committee.
06/09 – 10/10 – Syneron Medical Ltd.
General Manager of Syneron in Israel. In addition to managing the Israeli site, responsible for the Dental Division as well as the joint venture in China. Started the home use activity of Syneron as well as the skin whiting activities.
05/09: Galil Medical Ltd.